These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 31052559)

  • 21. Comparative modeling of PON2 and analysis of its substrate binding interactions using computational methods.
    Barathi S; Charanya M; Muthukumaran S; Angayarkanni N; Umashankar V
    J Ocul Biol Dis Infor; 2010 Jun; 3(2):64-72. PubMed ID: 22319641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paraoxonases and psoriasis: negative imbalance of antioxidant endogenous mechanisms.
    Schiattarella M; Caiazzo G; Di Caprio R; Lembo S; Raimondo A; Ayala F; Balato N; Monfrecola G; Fortunato G; Balato A
    G Ital Dermatol Venereol; 2019 Apr; 154(2):192-196. PubMed ID: 28509526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.
    Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI
    Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paraoxonase and atherosclerosis-related cardiovascular diseases.
    Chistiakov DA; Melnichenko AA; Orekhov AN; Bobryshev YV
    Biochimie; 2017 Jan; 132():19-27. PubMed ID: 27771368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report.
    Bahrehmand F; Vaisi-Raygani A; Rahimi Z; Ahmadi R; Kiani A; Tavilani H; Vaisi-Raygani H; Pourmotabbed T
    Lupus; 2014 Mar; 23(3):263-72. PubMed ID: 24399815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence of Paraoxonases 1, 2, and 3 Expression in Human Ovarian Granulosa Cells.
    Pérez-Ruiz I; Ruiz-Sanz JI; Hérnandez ML; Navarro R; Ferrando M; Larreategui Z; Ruiz-Larrea MB
    Antioxidants (Basel); 2021 Sep; 10(10):. PubMed ID: 34679639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The paraoxonase 1, 2 and 3 in humans.
    Rajkovic MG; Rumora L; Barisic K
    Biochem Med (Zagreb); 2011; 21(2):122-30. PubMed ID: 22135851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paraoxonase gene polymorphisms, oxidative stress, and diseases.
    Li HL; Liu DP; Liang CC
    J Mol Med (Berl); 2003 Dec; 81(12):766-79. PubMed ID: 14551701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of advanced glycation end product on paraoxonase 2 expression: Its impact on endoplasmic reticulum stress and inflammation in HUVECs.
    Ravi R; Ragavachetty Nagaraj N; Subramaniam Rajesh B
    Life Sci; 2020 Apr; 246():117397. PubMed ID: 32032646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the role of paraoxonases in the pathogenesis of coronary artery disease: a systematic review.
    Abelló D; Sancho E; Camps J; Joven J
    Int J Mol Sci; 2014 Nov; 15(11):20997-1010. PubMed ID: 25405733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PPARs in Regulation of Paraoxonases: Control of Oxidative Stress and Inflammation Pathways.
    Camps J; García-Heredia A; Rull A; Alonso-Villaverde C; Aragonès G; Beltrán-Debón R; Rodríguez-Gallego E; Joven J
    PPAR Res; 2012; 2012():616371. PubMed ID: 22315585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paraoxonase-1 is only present in traceable amounts in seminal fluid and does not show any relationship with male subfertility.
    Marsillach J; Lafuente R; Checa MA; Maestre-Martínez C; Fabián E; Brassesco M; Beltrán-Debón R; Aragonès G; Carreras R; Pedro-Botet J; Joven J; Camps J
    BJU Int; 2011 Aug; 108(4):566-70. PubMed ID: 21091978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of paraoxonase 1 activity in cardiovascular disease: potential for therapeutic intervention.
    Mackness MI; Durrington PN; Mackness B
    Am J Cardiovasc Drugs; 2004; 4(4):211-7. PubMed ID: 15285696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paraoxonase as a risk marker for cardiovascular disease: facts and hypotheses.
    Laplaud PM; Dantoine T; Chapman MJ
    Clin Chem Lab Med; 1998 Jun; 36(7):431-41. PubMed ID: 9746266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice.
    Rozenberg O; Rosenblat M; Coleman R; Shih DM; Aviram M
    Free Radic Biol Med; 2003 Mar; 34(6):774-84. PubMed ID: 12633754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family.
    Primo-Parmo SL; Sorenson RC; Teiber J; La Du BN
    Genomics; 1996 May; 33(3):498-507. PubMed ID: 8661009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary antioxidants and paraoxonases against LDL oxidation and atherosclerosis development.
    Aviram M; Kaplan M; Rosenblat M; Fuhrman B
    Handb Exp Pharmacol; 2005; (170):263-300. PubMed ID: 16596803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences.
    Aviram M; Rosenblat M
    Curr Opin Lipidol; 2005 Aug; 16(4):393-9. PubMed ID: 15990587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paraoxonase activity as a marker of exposure to xenobiotics in tobacco smoke.
    Milnerowicz H; Kowalska K; Socha E
    Int J Toxicol; 2015; 34(3):224-32. PubMed ID: 25953737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paraoxonase 3: Structure and Its Role in Pathophysiology of Coronary Artery Disease.
    Priyanka K; Singh S; Gill K
    Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31816846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.